Skip to main content
. Author manuscript; available in PMC: 2018 Dec 1.
Published in final edited form as: Cancer Epidemiol. 2017 Oct 16;51:62–67. doi: 10.1016/j.canep.2017.10.009

Table 3.

Multivariable-adjusted CVD risk among women with EC compared with cancer-free women in the Women’s Health Initiative, overall and stratified by Type I vs. II, n=93,607

Variable CV events/N CHR (95% CI)1 p
Overall (Type I and II)
EC status2 0.92
 No 15,740/92,217 (17%) 1.00
 Yes 212/1,390 (15%) 1.01 (0.87, 1.16)
BMI <0.001
 Normal weight (<25 kg/m2) 5,139/35,319 (15%) 1.00
 Overweight (25–29 kg/m2) 5,387/31,707 (17%) 1.13 (1.09, 1.18)
 Obese (≥30 kg/m2) 5,277/25,717 (21%) 1.45 (1.39, 1.51)
Hypertension history <0.001
 Never hypertensive 8,449/62,112 (14%) 1.00
 Untreated hypertensive 1,460/6,761 (22%) 1.58 (1.50, 1.68)
 Treated hypertensive 5,140/19,832 (26%) 1.86 (1.80, 1.93)
Type I
EC status2 <0.001
 No 15,740/92,217 (17%) 1.00
 Yes 186/1,179 (16%) 0.98 (0.84, 1.14)
BMI <0.001
 Normal weight (<25 kg/m2) 5,129/35,250 (15%) 1.00
 Overweight (25–29 kg/m2) 5,377/31,644 (17%) 1.13 (1.09, 1.18)
 Obese (≥30 kg/m2) 5,271/25,640 (21%) 1.46 (1.40, 1.52)
Hypertension history <0.001
 Never hypertensive 8,432/6,1974 (14%) 1.00
 Untreated hypertensive 1,460/6,747 (22%) 1.59 (1.50, 1.68)
 Treated hypertensive 5,133/19,784 (26%) 1.87 (1.80, 1.93)
Type II
EC status2
 No 15,740/92,217 (17%) 1.00 0.17
 Yes 26/211 (12%) 1.32 (0.88, 1.97)
BMI <0.001
 Normal weight (<25 kg/m2) 5,096/34,946 (15%) 1.00
 Overweight (25–29 kg/m2) 5,344/31,390 (17%) 1.13 (1.09, 1.18)
 Obese (≥30 kg/m2) 5,180/25,238 (21%) 1.46 (1.40, 1.52)
Hypertension history <0.001
 Never hypertensive 8,355/61,357 (14%) 1.00
 Untreated hypertensive 14,49/6,678 (22%) 1.59 (1.50, 1.68)
 Treated hypertensive 5,075/19,560 (26%) 1.87 (1.80, 1.94)
History of cancer (non-endometrial) 0.31
 No 14,562/85,644 (17%) 1.00
 Yes 1,051/6,035 (17%) 1.03 (0.97, 1.10)
1

Cox proportional hazards regression models with baseline hazards stratified by trial membership (OS, E+P, DM, E+P and DM) and age as the underlying time scale with adjustment for variables shown

2

EC status was treated as a time-varying covariate

CHR: Cause-specific hazard ratio